Same Brand, Different EBITDA: What the FFS Exit Wave Reveals

Why Are Two of Your Locations Producing Different EBITDA on the Same Brand?

The group operator in this data pattern had already ruled out the obvious explanations. Same associate tenure. Same hygiene team size. Similar zip code demographics and household income. The fee schedule was identical across both locations. The brand standards were identical.

The production gap was not closing. It had been stable at 28 percent below projection for three consecutive quarters.

The Dental Index national practice audit found that EBITDA variance between same-brand DSO locations is, in the majority of cases, not an operations problem. Your instinct to audit staffing, scheduling efficiency, and front-desk conversion rates is not wrong. But if you have already run those audits and the gap persists, you are looking at a positioning problem wearing an operations mask.

The brand signals what the group stands for. The market position signals what a specific location stands for in the specific market it operates in. Those are not the same thing. A brand can be consistent across every location while market position varies by 60 points on an AI readiness scale. Your EBITDA numbers already know this. Your management model may not.

What Is the FFS Exit Wave Actually Showing You About Your Portfolio?

The 2025 wave of solo practices dropping insurance contracts is producing data that most DSO operators are watching primarily for acquisition opportunities. The practices struggling post-transition are discounting to stay competitive. The ones holding revenue are not.

The difference is not clinical quality or geographic luck. The Dental Index national practice audit documents that out-of-network positioning in high-income markets can increase net revenue per patient by 30 to 50 percent. But the practices capturing that gain were the ones whose positioning was built before the transition, not after it. Patients found them through Google Maps or an AI search, chose them based on what they stood for, and arrived pre-sold on fee-for-service pricing.

The practices that lost production after dropping insurance were not positioned to hold. AI search and Google Maps could not route the right patients to them. When the volume of insurance panels was removed, the positioning gap became a revenue gap within two billing cycles.

Your portfolio has FFS exposure whether it is tracking it or not. Every location in a market where patients are shifting away from insurance-directed care is either positioned to capture that shift or positioned to watch it route to the practice next door. The FFS exit wave is not generating data about solo practices. It is generating data about positioning durability under conditions your own locations will eventually face. The question is whether you are reading it that way.

What Variable Are Your Underperforming Locations Consistently Missing?

When an AI readiness audit was run across the 18-location portfolio in the pattern above, the correlation was immediate. The two top EBITDA performers had AI readiness scores of 71 and 68 out of 100. The three lowest EBITDA performers scored 31, 24, and 19.

The pattern held across the middle of the portfolio. The locations ranking higher on revenue per patient were not the newest facilities or the ones in the wealthiest zip codes. They were the ones that AI search could read clearly enough to route patients toward.

The Dental Index national practice audit found that fewer than 8 percent of US dental practices have an AI readiness score above 65 out of 100, and the national average sits below 40. Your portfolio almost certainly reflects this distribution. Across 15 locations, statistical likelihood says one or two are above that 65 threshold. The rest are leaving revenue in the gap between what they are positioned to provide and what patients can find when they search for it.

The missing variable is signal clarity. AI search does not rank practices on clinical quality, years in business, or brand recognition at the group level. It routes patients to the practices whose positioning most clearly matches the search intent. If your location is positioned as a dental practice rather than as the destination for implants in its specific market, AI search does not route implant patients to it. The demand is there. The capture is not.

Source: The Dental Index national practice audit, 2026

Is Your Pre-Acquisition Diligence Pricing the Right Variables?

The practices entering the acquisition market out of the FFS transition are presenting with strong trailing production numbers. Three years of revenue above national median. EBITDA margins reflecting the net revenue lift of out-of-network fee schedules. A patient base that has self-selected toward higher-value care.

Some of those practices are genuinely durable acquisitions. Some are one patient discovery cycle away from a volume problem.

The Dental Index national practice audit found that 70 percent of dental practices are invisible to AI-referred patients. That includes practices with strong recent production. If a practice's patient volume is sustained by hygiene recall loyalty and word-of-mouth in a network that has not yet shifted to AI search as the primary discovery tool, the trailing twelve months is not a reliable forward indicator. The moment that network changes its discovery behavior, a practice with an AI readiness score below 30 faces a patient acquisition challenge it has never had to solve before.

Your diligence model is probably pricing fee schedules, payer mix, provider transition risk, and lease terms. It is not pricing AI search visibility as a forward revenue signal. That gap is where acquisitions get overvalued.

The practices worth the multiple are the ones whose production is positioned to hold when patients arrive through AI search rather than through a hygienist referral or an insurance directory. That is a measurable variable today. It belongs in your diligence package.

EBITDA variance between identical-brand locations is positioning variance: the brand is the same, but the market position is not.

What Do Your Highest-Performing Locations Do That the Others Do Not?

Across The Dental Index national practice audit, the same-brand locations producing the highest revenue per patient and the most stable EBITDA share three positioning characteristics that have nothing to do with the brand itself.

• Procedure-specific signal clarity: They do not appear in AI search as a generic dental practice. They appear as the destination for specific high-value procedures in their specific market. AI search routes implant patients to them because the positioning signal is readable at the procedure level, not just at the category level. If your location's patient discovery signal says nothing specific about what it does best, AI search has no reason to surface it over a competitor that is more specific.
• Complete patient discovery infrastructure: The Dental Index data shows that practices with fully completed GBP profiles receive 7 times more AI-referred clicks than those without. Your highest-performing locations are not capturing more patient traffic because they are better at dentistry. They are capturing it because AI search can read them clearly enough to send traffic their way. Your underperforming locations have the same opportunity. Most have not taken it.
• High-value patient type alignment: AI-referred patients book high-value procedures at 2 to 3 times the rate of patients arriving through other channels. Implant demand is growing at 8.5 percent annually. Cosmetic demand at 6.8 percent annually. Your top EBITDA locations are capturing a disproportionate share of that growth because their positioning aligns with what those patients are already searching for. The same demand exists in your underperforming markets. The capture does not.

These are not brand decisions made at the group level. They are positioning decisions made at the location level, consciously or not. Your underperforming locations have the same brand. They do not have the same market position. The gap between those two things is your EBITDA gap.

How Does This Pattern Play Out Across a Full Portfolio?

Of the 18 locations in this data pattern, 14 had AI readiness scores below 40.

Three were between 40 and 65.

One was above 65.

That one location was the portfolio's highest-performing site by revenue per patient. It was not a coincidence.

Six weeks after the positioning work began at the underperforming comparison location, the AI readiness score had moved from 24 to 61. Revenue per patient had not shifted yet. New patients take time to book, consult, and convert. But the inquiry pattern had already changed. The calls coming in were for implants and complex restorative cases. The procedure conversations were different from day one.

The EBITDA line would follow.

If your portfolio shows a similar distribution, the audit data is already telling you where to start. And the location with the largest positioning gap is almost certainly not the location you would have guessed before you ran the numbers.

What Does Your AI Readiness Variance Tell You About Portfolio Risk Right Now?

There are 432,000 AI dental searches happening nationally every month. Those searches are routing to a small number of practices with clear, procedure-level positioning signals that AI can read, rank, and route patients toward. Across a portfolio of 10 or more locations, capturing a meaningful share of that demand is an operations function, not a positioning aspiration. It belongs on the same management cadence as scheduling efficiency and hygiene retention.

Your positioning only reaches patients if AI search and Google Maps can read it. The locations in your portfolio with AI readiness scores below 40 are not invisible on Google generally. They are invisible to the patients most likely to choose them: patients arriving through AI search with a specific procedure in mind, a specific type of practice in mind, a specific level of care already decided. Those patients are not finding them. They are finding the competitor nearby whose signal AI can read clearly enough to send traffic there instead.

In 2026, your EBITDA variance is your visibility variance. The gap between your top-performing location and your lowest performer is, at its root, the gap between what patients can find and what they cannot. That is auditable today. The locations in your portfolio that have not built a clear positioning signal at the location level are ceding demand that is already in their markets, quarter by quarter, to practices that made AI readiness a management KPI before it showed up as a line item in their revenue variance. Your positioning only reaches the patients who would choose you if they can find you first, and in 2026 that means your practice showing up in AI search and Google Maps before the practice two miles away does.